USE OF NEUROGLOBIN AGONIST FOR PREVENTING OR TREATING MITOCHONDRIAL RCCI AND/OR RCCIII DEFICIENCY DISEASE,申请号WO2014EP70991-传众专利搜索

发明名称	USE OF NEUROGLOBIN AGONIST FOR PREVENTING OR TREATING MITOCHONDRIAL RCCI AND/OR RCCIII DEFICIENCY DISEASE
摘要	The present invention concerns a neuroglobin agonist for use in the treatment or prevention of a mitochondrial disease associated with respiratory chain complex I (RCCI) deficiency and/or respiratory chain complex III (RCCIII) deficiency.
申请公布号	WO2015044462(A1)	申请公布日期	2015.04.02
申请号	WO2014EP70991	申请日期	2014.09.30
申请人	SANOFI;UNIVERSITÉ PIERRE ET MARIE CURIE (PARIS 6);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S);INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)	发明人	CORRAL-DEBRINSKI, MARISOL;LECHAUVE, CHRISTOPHE;SAHEL, JOSÉ-ALAIN;DEBEIR, THOMAS
分类号	A61K38/42;A61K48/00;A61P1/16;A61P3/08;A61P25/00;A61P25/08;A61P27/02;C12N15/86	主分类号	A61K38/42
代理机构		代理人
主权项
地址